HomeADIL • NASDAQ
add
Adial Pharmaceuticals Inc
Previous close
$0.31
Day range
$0.31 - $0.32
Year range
$0.22 - $1.30
Market cap
7.52M USD
Avg Volume
456.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.76M | -20.23% |
Net income | -1.79M | 18.17% |
Net profit margin | — | — |
Earnings per share | -0.08 | 78.95% |
EBITDA | -1.76M | 20.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.61M | -11.49% |
Total assets | 5.66M | -15.68% |
Total liabilities | 1.15M | 39.29% |
Total equity | 4.51M | — |
Shares outstanding | 23.99M | — |
Price to book | 1.63 | — |
Return on assets | -70.78% | — |
Return on capital | -87.37% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.79M | 18.17% |
Cash from operations | -1.83M | -8.22% |
Cash from investing | 0.00 | — |
Cash from financing | 524.68K | -85.47% |
Net change in cash | -1.31M | -168.29% |
Free cash flow | -1.26M | -37.11% |
About
Founded
2010
Headquarters
Website
Employees
5
